FOXO4-DRI is an experimental research peptide studied in the field of cellular senescence, the process in which aging or damaged cells stop dividing but remain biologically active. It was designed to interfere with the interaction between two proteins known as FOXO4 and p53.
Laboratory and animal research has examined whether disrupting this interaction can influence the survival of senescent cells while helping scientists better understand their role in aging and tissue function. This has made FOXO4-DRI an area of interest in cellular aging, senescence, and longevity-related research.
Ophir Health FOXO4-DRI provides a precisely measured format for laboratory research involving FOXO4-p53 signaling, cellular senescence, aging biology, and senescent-cell research.
